Tesamorelin is studied in growth-hormone-releasing hormone analog research, endocrine signaling, and body-composition models.
Research Use Only
Tesamorelin — GHRH Analog RUO Box
A tesamorelin packaged as a plastic box containing 10 vials in the selected strength.
10x tesamorelin vials in the selected strength • CAS 218949-48-5 • 5136 g/mol • Research-use-only box • 10-vial kit
Tesamorelin Structure
Reference identifiers are batch-specific for coded materials and are documented on the lot COA/SDS rather than inferred or estimated.
Mechanism of Action
Tesamorelin Overview
The Tesamorelin is packaged as a plastic box containing 10 lyophilized tesamorelin vials for research use only. This listing reflects the RUO tesamorelin box strengths shown on the reference sheet.
Purity & Testing
Tesamorelin is listed as 10x tesamorelin vials in the selected strength. Catalog identity: CAS 218949-48-5; formula C221H366N72O67S; molecular weight 5136 g/mol. The lot COA for Tesamorelin is available in your account. Finnrick Analytical performs HPLC purity analysis and mass spectrometry identity confirmation on that lot.
- Kit contents: 10x tesamorelin vials in the selected strength
- Catalog configurations: 5mg vials x 10, 10mg vials x 10
- CAS: 218949-48-5
- Formula: C221H366N72O67S
- Molecular weight: 5136 g/mol
See the Tesamorelin COA page.
Storage & Handling
Store the lyophilized powder at -20°C, protected from light; bring to room temperature before opening. For in-vitro preparation use an appropriate laboratory diluent.
Shipping
Ships worldwide from US, China, or Canada warehouses
Available for direct research purchase
Research-use-only products are sold strictly for laboratory and research purposes. By purchasing, you acknowledge that these products are not intended for human or veterinary use, and you agree to PharmaOrder's RUO terms of service.
Published Research
These citations are already published on the matching peptide page and describe the compound, not a lot test.
Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial
Falutz J, Allas S, Blot K, et al. — JAMA (2007)
Randomized trial examining tesamorelin's effect on visceral adipose tissue in an HIV-associated lipodystrophy model.
Tesamorelin, a human growth hormone-releasing factor analogue, for the treatment of visceral adipose tissue accumulation in HIV-infected patients
Falutz J, Potvin D, Mamputu JC, et al. — Journal of Clinical Endocrinology & Metabolism (2010)
Phase III extension study examining tesamorelin's visceral adipose tissue endpoints in an extended-duration model.
Growth hormone-releasing hormone in HIV lipodystrophy: a randomized controlled trial
Stanley TL, Chen CY, Branch KL, et al. — JAMA (2014)
Randomized trial examining tesamorelin's visceral fat, hepatic lipid, and lipid-profile endpoints in an HIV lipodystrophy model.
FAQ
What strengths are available in the tesamorelin kit?
Current box formats listed for this research kit are: 5mg vials x 10, 10mg vials x 10.
What is included in the tesamorelin kit?
Each tesamorelin research kit is a plastic box containing 10 vials in the selected strength. It does not imply the inclusion of bacteriostatic water, syringes, or swabs.
How should the tesamorelin kit be stored?
Store the boxed vials according to the label guidance for the product and keep the kit protected from excessive heat, moisture, and light during storage.
Editorial Review
Updated March 2026. Reviewed against product catalog, quality, and fulfillment standards. This page is educational and not instructions for human use. See our editorial standards and quality process.
Related Products
Ready to order Tesamorelin?
In stock. Ships within 24 hours, with tracking.
Order Now